Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients

Table 2 Echocardiographic parameters

Variable	Patients without LVDD n = 78 Mean	Patients with LVDD n = 75 Mean	p value
EF (%)	60 ± 6.2	56 ± 10	0.03
E (cm/s)	78 ± 15	79 ± 18	0.8
A (cm/s)	68 ± 15	97 ± 57	0.001
Edt (s)	0.2 ± 0.06	0.2 ± 0.05	0.2
Pulmonary vein flow	1.4 ± 0.7	1.2 ± 0.6	0.2
RA diameter (mm/m²)	24 ± 4,5	25 ± 4.4	0.3
IVSDd (mm/m²)	5.8 ± 1.0	6.0 ± 0.8	0.3
LVIDd (mm/m²)	24 ± 2.5	24 ± 2.6	0.5
RVIDd (mm/m²)	14 ± 1.9	15 ± 2.2	0.2
PWDd (mm/m²)	4.6 ± 0.7	4.5 ± 0.7	0.6
PSVsept (cm/s)	9.2 ± 6.8	7.7 ± 1.6	0.1
Èsept (cm/s)	10 ± 6.7	6.7 ± 1.8	0.001
Ásept (cm/s)	9.3 ± 2.0	10 ± 2.6	0.06
PSVlat (cm/s)	8.9 ± 2.4	8.4 ± 2.0	0.2
Élat (cm/s)	11 ± 3.2	9.1 ± 2.3	< 0.001
Álat (cm/s)	10 ± 3.6	11 ± 3.1	0.2
LA diameter (mm/m²)	20 ± 2.3	20 ± 1.9	0.7
LVM (g/m²⁾	87 ± 22	88 ± 25	0.9

Data are expressed as mean ± SD. BSA; body surface area, EF; ejection fraction, E; peak early mitral valve velocity, A; peak late atrial mitral valve velocity, Edt; deceleration time, LA; left atrium, RA; right atrium, IVSDd; interventricular systolic diameter diastole, LVIDd; left ventricular inner diameter diastole, RVIDd; right ventricular inner diameter diastole, PWDd; posterior wall diameter diastole, PSVsep; peak systolic myocardial velocity at mitral annulus in septal wall, Ésept; early diastolic tissue velocity at mitral annulus in septal wall, Ásept; late diastolic tissue velocity at mitral annulus in septal wall, PSVlat; peak systolic myocardial velocity at mitral annulus in lateral wall, Élat; early diastolic tissue velocity at mitral annulus in lateral wall, Álat; late diastolic tissue velocity at mitral annulus in lateral wall, LVM; left ventricular mass.